EMBC · Embecta Corp
United States · RS rating 55 · As of 2026-10-14
| Price | 6.18 USD |
|---|---|
| 1-day change | -0.3% |
| RS rating (overall / 1M / 3M / 12M) | 55 / 97 / 97 / 13 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 30 / 25 / 28 |
| Industry group (rank) | Medical-Supplies (63) |
| EPS growth Q/Q | +64.4% |
| Sales growth Q/Q | -1.1% |
| Distance from 52-week high | +57.8% |
| Market cap (USD) | $541.9M |